SSB
NERV icon

Sandy Spring Bank’s Minerva Neurosciences NERV Stock Holding History

Sandy Spring Bank’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$319 – 1274
2024
Q2 		$319 Hold
100
– – ﹤0.01% 1200
2024
Q1 		$258 Buy
+100
New +$614 ﹤0.01% 1179

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Sandy Spring Bank's NERV Position: Q3 2024 in Review

Sandy Spring Bank sold out of Minerva Neurosciences (NERV) in Q3 2024, closing a stake of 100 shares — an estimated $319 sold.

Sandy Spring Bank first reported a position in NERV in Q1 2024 and held it in 2 quarters. The position peaked at $319 in Q2 2024. 21 funds tracked by Wall St. Rank hold NERV as of Q3 2024.

  • Sandy Spring Bank reported no remaining Minerva Neurosciences position as of Q3 2024 after selling out during the quarter.
  • Sandy Spring Bank sold 100 Minerva Neurosciences shares in Q3 2024, an estimated $319.
  • Sandy Spring Bank first reported a position in Minerva Neurosciences in Q1 2024 and held it in 2 quarters.
  • Sandy Spring Bank's Minerva Neurosciences position peaked at $319 in Q2 2024.
  • 21 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2024.

Based on Sandy Spring Bank's 13F filing for Q3 2024, filed 25 Oct 2024.